TKI Treatment Discontinuation: How Many Patients Could Stop Tyrosine Kinase Treatment According to Discontinuation Trials Criteria? Incidence and Prognostic Impact of Deep Molecular Response in a Cohort of Chronic Myeloid Leukemia Patients of South Brazil’s Hematology Centers

Autor:	Fogliatto, Laura *, Capra, Marcelo Eduardo Zanella *, Shaan, Mariza *, Vanelli Costa, Tito *, Contin, Luis Carlos Zanandrea *, Breunig, Raquel *, Silveira, Juarez Fontoura *, Torriani, Mayde Seadi *, Fassina, Katia *, Fernandes, Mario Sergio *, Almeida, Denise *, Schilling, Marco Antonio *, Hellwig, Tânia *, Daltoe, Tiago *, Moschen, Mariangela *, Zardo, Adriana *, Nene, Moema *, Daudt, Liane Esteves *, Friedrisch, João *, Silla, Lucia
Zdroj:	In Blood 6 December 2014 124(21):5542-5542
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu